The use of GAP-43 mRNA quantification in high throughput screening of putative neuroprotective agents in dorsal root ganglion cultures

Journal of Neuroscience Methods

Volumn 136, Issue 2, 2004, Pages 193-195

  Keswani, Sanjay C ^a   Rosenberg, Brian ^a   Hoke, Ahmet ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

GAP 43; High throughput assay; Immunophilin ligand; Neuroprotection

Indexed keywords

ANTIRETROVIRUS AGENT; IMMUNOPHILIN; MESSENGER RNA; NEUROMODULIN; NEUROPROTECTIVE AGENT; TACROLIMUS; ZALCITABINE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; GENE EXPRESSION; HIGH THROUGHPUT SCREENING; MORPHOLOGY; NEURITE; NEUROPROTECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SPINAL GANGLION;

ANIMALS; ANIMALS, NEWBORN; CELL CULTURE TECHNIQUES; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; FETUS; GANGLIA, SPINAL; GAP-43 PROTEIN; GENE EXPRESSION; NERVE DEGENERATION; NEURONS; NEUROPROTECTIVE AGENTS; RATS; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TACROLIMUS; ZALCITABINE;

EID: 2942623919     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2004.01.004     Document Type: Article

References (10)

1. Benowitz L.I., Routtenberg A. GAP-43: an intrinsic determinant of neuronal development and plasticity. Trends Neurosci. 20(2):1997;84-91
2. Biffo S., Verhaagen J., Schrama L.H., Schotman P., Danho W., Margolis F.L. B-50/GAP43 expression correlates with process outgrowth in the embryonic mouse nervous system. Eur. J. Neurosci. 2(6):1990;487-499
3. Curtis R., Stewart H.J., Hall S.M., Wilkin G.P., Mirsky R., Jessen K.R. GAP-43 is expressed by nonmyelin-forming Schwann cells of the peripheral nervous system. J. Cell Biol. 116(6):1992;1455-1464
4. Irwin N., Madsen J.R. Molecular biology of axonal outgrowth. 1. Growth cones and GAP-43. Pediatr. Neurosurg. 27(3):1997;113-120
5. Jap Tjoen San E.R., Schmidt-Michels M.H., Spruijt B.M., Oestreicher A.B., Schotman P., Gispen W.H. Quantitation of the growth-associated protein B-50/GAP-43 and neurite outgrowth in PC12 cells. J. Neurosci. Res. 29(2):1991;149-154
6. Johnson P.H., Walker R.P., Jones S.W., Stephens K., Meurer J., Zajchowski D.A., et al. Multiplex gene expression analysis for high-throughput drug discovery: screening and analysis of compounds affecting genes overexpressed in cancer cells. Mol. Cancer Ther. 1(14):2002;1293-1304
7. Keswani S.C., Chander B., Hasan C., Griffin J.W., McArthur J.C., Hoke A. FK506 is neuroprotective in a model of antiretroviral toxic neuropathy. Ann. Neurol. 53(1):2003;57-64
8. Masimirembwa C.M., Thompson R., Andersson T.B. In vitro high throughput screening of compounds for favorable metabolic properties in drug discovery. Comb. Chem. High Throughput Screen. 4(3):2001;245-263
9. Reynolds M.L., Fitzgerald M., Benowitz L.I. GAP-43 expression in developing cutaneous and muscle nerves in the rat hindlimb. Neuroscience. 41(1):1991;201-211
10. Woolf C.J., Reynolds M.L., Chong M.S., Emson P., Irwin N., Benowitz L.I. Denervation of the motor endplate results in the rapid expression by terminal Schwann cells of the growth-associated protein GAP-43. J. Neurosci. 12(10):1992;3999-4010